HEBDOLIN
Live / Registered — Registered (as of 22 Feb 2022)
What this means for you
Registered since 22 Feb 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87812074
- Registration number
- 6653913
- Mark type
- Stylized text
- Filed
- 27 Feb 2018
- Published for opposition
- 17 Jul 2018
- Registered
- 22 Feb 2022
- Attorney of record
- Bradley M. Stohry
Goods and services
- Class 005 — Pharmaceuticals: Insulin; Veterinary preparations for treating diabetes; Pharmaceutical preparations for treating diabetes
Owner
- Akston Biosciences Corporation, Beverly, MA, US
- Akston Biosciences Corporation, Beverly, MA, US
- Akston Biosciences Corporation, Beverly, MA, US
Prosecution history
- 22 Feb 2022 — REGISTERED-PRINCIPAL REGISTER
- 20 Jan 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 19 Jan 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 08 Dec 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 08 Dec 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 08 Dec 2021 — ASSIGNED TO LIE
- 06 Dec 2021 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 07 Jun 2021 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 07 Jun 2021 — NON-FINAL ACTION E-MAILED
- 07 Jun 2021 — SU - NON-FINAL ACTION - WRITTEN
- 10 May 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 07 May 2021 — USE AMENDMENT FILED
- 07 May 2021 — TEAS STATEMENT OF USE RECEIVED
- 09 Mar 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Mar 2021 — SOU EXTENSION 5 GRANTED